Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02963051
Recruitment Status : Terminated (Study stopped due to lack of efficacy.)
First Posted : November 15, 2016
Last Update Posted : March 5, 2020
Sponsor:
Collaborators:
Give 1 For Dad Campaign
The V Foundation for Cancer Research
Peter Michael Foundation
Cantex Pharmaceuticals
Information provided by (Responsible Party):
Daniel George, MD, Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 30, 2018
Actual Study Completion Date : February 1, 2020